Bhaven N. Sampat

bns.png

I am an Associate Professor at the Department of Health Policy and Management at Columbia University and a Research Associate at the National Bureau of Economic Research (NBER).

My research focuses on the economics and political economy of science and technology, primarily in the life sciences. My current projects examine:

My previous work includes research on the political economy of the the NIH, the economic impact of public science, patent data as economic indicators, the law and economics of the patent system, pharmaceutical and life science patent policy, and university-industry technology transfer, among other topics.

You can find my CV here and my Google Scholar Profile here.

Recent research and writing

Gross, Daniel P., and Bhaven N. Sampat "Crisis Innovation Policy: A Historical Perspective" American Economic Review Papers and Proceedings (forthcoming, 2021)

Sampat, Bhaven N. "The Government and Pharmaceutical Innovation: Looking Back and Looking Forward" Journal of Law, Medicine, and Ethics (forthcoming, 2021)

Gross, Daniel P., and Bhaven N. Sampat "Organizing Crisis Innovation: Lessons From World War II" NBER Working Paper 27909 (2020).

Gross, Daniel P., and Bhaven N. Sampat. "Inventing the Endless Frontier: The Effects of the World War II Research Effort on Post-War Innovation." NBER Working Paper 27375 (2020).

Sampat, Bhaven N. "Whose Drugs Are These?" Issues in Science and Technology 36.4 (2020)

Margaret Kyle, Ken Shadlen, and Bhaven N. Sampat. "TRIPS, Patents, and Drug Prices in India" (2020) (email for copy)

Bryan, Kevin A., Yasin Ozcan, and Bhaven Sampat. "In-text patent citations: A user's guide." Research Policy 49 (2020): 103946.

Shadlen, Kenneth C., Bhaven N. Sampat, and Amy Kapczynski. "Patents, trade and medicines: past, present and future." Review of International Political Economy 27 (2020): 75-97.

Sampat, Bhaven N., and Heidi L. Williams. "How do patents affect follow-on innovation? Evidence from the human genome." American Economic Review 109 (2019): 203-36.

Azoulay, Pierre, Graff-Zivin, Joshua, Li, Danielle, and Bhaven N. Sampat "Public R&D investments and private-sector patenting: evidence from NIH funding rules." The Review of Economic Studies 86 (2019): 117-152.

Sampat, Bhaven N. "A Survey of Empirical Evidence on Patents and Innovation" NBER Working Paper 25383 (2018)

Sampat, Bhaven N., and Kenneth C. Shadlen. "Indian pharmaceutical patent prosecution: The changing role of Section 3(d)." PloS ONE (2018): e0194714.

Sampat, Bhaven N., and Kenneth C. Shadlen. "Secondary pharmaceutical patenting: A global perspective." Research Policy (2017): 693-707.

Li, Danielle, Pierre Azoulay, and Bhaven N. Sampat. "The applied value of public investments in biomedical research." Science (2017): 78-81.

Teaching

2020-2021

  • Vaccine Innovation and Public Policy
  • The Economics of Biomedical Research
  • Innovations in Health Policy
  • The Economics of Precision Medicine

Earlier

  • Science, Evidence, and Politics in Health Policy (with Ronald Bayer)
  • Integration of Science and Practice
  • Program Evaluation
  • Research Methods I/II
  • Economics of Innovation (doctoral seminar, at ASU)
  • Science, Technology, and Sustainable Development (doctoral seminar, at SIPA)
  • Health and Development (at SIPA)
  • U.S. Science and Technology Policy (at SIPA)

Professional Activities